Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1435-5922
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy ; day:4 ; month:5 ; year:2017 ; pages:1-12
Journal of gastroenterology ; (4.5.2017), 1-12

Keyword
Krebs
Onkologie

Creator
Masuda, Kazuhiko
Contributor
Ono, Atsushi
Aikata, Hiroshi
Kawaoka, Tomokazu
Nelson Hayes, C.
Teraoka, Yuji
Daijo, Kana
Nakamura-Inagaki, Yuki
Morio, Kei
Fujino, Hatsue
Kan, Hiromi
Uchida, Takuro
Masaki, Keiichi
Kobayashi, Tomoki
Nakahara, Takashi
Makokha, Grace Naswa
Zhang, Yizhou
Nagaoki, Yuko
Miki, Daiki
Tsuge, Masataka
Hiramatsu, Akira
Imamura, Michio
Abe-Chayama, Hiromi
Kawakami, Yoshiiku
Ochi, Hidenori
Chayama, Kazuaki
SpringerLink (Online service)

DOI
10.1007/s00535-017-1348-8
URN
urn:nbn:de:1111-2017051410756
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Masuda, Kazuhiko
  • Ono, Atsushi
  • Aikata, Hiroshi
  • Kawaoka, Tomokazu
  • Nelson Hayes, C.
  • Teraoka, Yuji
  • Daijo, Kana
  • Nakamura-Inagaki, Yuki
  • Morio, Kei
  • Fujino, Hatsue
  • Kan, Hiromi
  • Uchida, Takuro
  • Masaki, Keiichi
  • Kobayashi, Tomoki
  • Nakahara, Takashi
  • Makokha, Grace Naswa
  • Zhang, Yizhou
  • Nagaoki, Yuko
  • Miki, Daiki
  • Tsuge, Masataka
  • Hiramatsu, Akira
  • Imamura, Michio
  • Abe-Chayama, Hiromi
  • Kawakami, Yoshiiku
  • Ochi, Hidenori
  • Chayama, Kazuaki
  • SpringerLink (Online service)

Other Objects (12)

Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma

Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma

Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial

Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation

Affaire Weeks : 1982 - 1988 = Weeks case

Affaire Weeks : 1982 - 1988 = Weeks case

Sorafenib : Sorafenib in der Behandlung des Radiojod-refraktären differenzierten Schilddrüsenkarzinoms

Sorafenib : Sorafenib in der Behandlung des Radiojod-refraktären differenzierten Schilddrüsenkarzinoms

HMGB1, neuronal excitability and epilepsy

HMGB1, neuronal excitability and epilepsy

HMGB1 in inflammation and cancer

HMGB1 in inflammation and cancer

Optimierung der Sorafenib-Therapie

Hochschulschrift

Optimierung der Sorafenib-Therapie

Infusion

Aufsatzsammlung

Infusion

Infusion

Abschnitt

Infusion

Infusion

Archivale

Infusion

Sorafenib-Induced Capillary Leak Syndrome

Sorafenib-Induced Capillary Leak Syndrome

Related objects